Top Markets
#1 OSK OSK +15.48%
#2 Ardor Ardor +7.80%
#3 MarsCoin MarsCoin +7.36%
#4 Tornado Cash Tornado Cash +6.57%
#5 HOME HOME +5.86%
#6 UnifAI Network UnifAI Network +4.33%
#7 AI XOVIA AI XOVIA +4.25%
#8 Story Story +4.12%
#9 Cash Cat Cash Cat +3.55%
#10 Anvil Anvil +2.93%
Coin of the day
OSK OSK
Settings
Language
ENGLISH
Currency
USD
Theme
Spectral Medical Inc. Spectral Medical Inc.

Spectral Medical Inc.

EDT
Rank in Stocks #16682
Spectral Medical Inc. focuses on the development and commercialization of... Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Share Price
$0.95411796
Last synced: 2026-09-01
Market Cap
$279.96M
Change (1 day)
-0.76%
Change (1 year)
-16.23%
Country
CA
Trade Spectral Medical Inc. (EDT)

Category

Healthcare
Revenue for Spectral Medical Inc. (EDT)
Revenue in Sep 2026 TTM: 0
According to Spectral Medical Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Spectral Medical Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B -
US